152 related articles for article (PubMed ID: 9356001)
1. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.
Anzueto A; Jubran A; Ohar JA; Piquette CA; Rennard SI; Colice G; Pattishall EN; Barrett J; Engle M; Perret KA; Rubin BK
JAMA; 1997 Nov; 278(17):1426-31. PubMed ID: 9356001
[TBL] [Abstract][Full Text] [Related]
2. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
Weg JG; Balk RA; Tharratt RS; Jenkinson SG; Shah JB; Zaccardelli D; Horton J; Pattishall EN
JAMA; 1994 Nov; 272(18):1433-8. PubMed ID: 7933425
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic aerosols and airway secretions.
Rubin BK
J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
6. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
[TBL] [Abstract][Full Text] [Related]
7. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Abbasi S; Bhutani VK; Gerdes JS
J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
[TBL] [Abstract][Full Text] [Related]
9. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.
Rubin BK
Chest; 1999 Jul; 116(1):195-200. PubMed ID: 10424525
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
Goldman SL; Bosque E; McCann E; Lewis K
J Pediatr; 1992 Feb; 120(2 Pt 2):S25-8. PubMed ID: 1735847
[TBL] [Abstract][Full Text] [Related]
11. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
12. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
Rubin BK; Ramirez O; King M
Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
[TBL] [Abstract][Full Text] [Related]
13. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
Courtney SE; Long W; McMillan D; Walter D; Thompson T; Sauve R; Conway B; Bard H
J Pediatr; 1995 May; 126(5 Pt 2):S43-52. PubMed ID: 7745510
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
15. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517
[TBL] [Abstract][Full Text] [Related]
16. Effect of terbutaline on mucociliary transport and sputum properties in chronic bronchitis.
Sadoul P; Puchelle E; Zahm JM; Jacquot J; Aug F; Polu JM
Chest; 1981 Dec; 80(6 Suppl):885-9. PubMed ID: 7030661
[TBL] [Abstract][Full Text] [Related]
17. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
Lancet; 1992 Dec; 340(8832):1363-9. PubMed ID: 1360087
[TBL] [Abstract][Full Text] [Related]
18. Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry.
Huang YC; Sane AC; Simonson SG; Fawcett TA; Moon RE; Fracica PJ; Menache MG; Piantadosi CA; Young SL
J Appl Physiol (1985); 1995 May; 78(5):1816-22. PubMed ID: 7649917
[TBL] [Abstract][Full Text] [Related]
19. Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
Sauve R; Long W; Vincer M; Bard H; Derleth D; Stevenson D; Pauly T; Robertson C
J Pediatr; 1995 May; 126(5 Pt 2):S75-80. PubMed ID: 7745515
[TBL] [Abstract][Full Text] [Related]
20. [Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
Mikhel'sonVA ; Grebennikov VA; Belaĭ VA; Everstova TN
Anesteziol Reanimatol; 1995; (1):4-7. PubMed ID: 7605034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
